Werfen Unveils QUANTA Link® 5.0: Transforming Autoimmune Lab Operations with a Web-Based Platform #United_States #San_Diego #Werfen #Autoimmunity #QUANTA_Link
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialWerfen Achieves Key Milestone with FDA and CE Approval for Aptiva Antiphospholipid Syndrome IgA Reagent #USA #San_Diego #Werfen #Aptiva #Antiphospholipid_Syndrome